top of page
gradientForSurfBreak.png

Item List

PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

Citizen Health Announces $14.5 Million Seed Funding and Partnerships to Transfor ...

Chan Zuckerberg Initiative

Portfolio Company

Carlsmed.png

xCures Unveils Next-Generation AI-Powered Data Platform ...

Engineering

Portfolio Company

Carlsmed.png

Gradient Health announces acquisition of DataAppraisal to accelerate medical AI ...

HealthCare Business

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page